Hydroxycarbamid

DRUG3 trials

Sponsors

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Theravia, Christer C Nilsson

Conditions

Central Retinal Vein Occlusion, Non-IschemicR/R AMLSickle Cell Disease

Phase 1

Addition of Hydroxyurea to Fludarabine, Cytarabine, Idarubicin and Venetoclax Salvage Therapy for Adults With Relapsed or Refractory Acute Myeloid Leukemia

Not yet recruitingNCT07766850

Christer C NilssonR/R AML

Start: 2026-10-01End: 2034-09-01Target: 26Updated: 2026-08-17

Phase 2

Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.

Centre Hospitalier National d'Ophtalmologie des Quinze-VingtsCentral Retinal Vein Occlusion, Non-Ischemic

Start: 2015-12-31End: 2017-12-31Target: 30Updated: 2016-11-28

Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children With Sickle Cell Disease

RecruitingNCT06578507

TheraviaSickle Cell Disease

Start: 2025-01-21End: 2027-02-28Target: 50Updated: 2025-09-17